Cite

HARVARD Citation

    de Stefano, N. et al. (2022). Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis. Neurology. 9 (4), p. . [Online]. 
  
Back to record